Fredrikson & Byron acted as legal counsel for Eurofins Scientific (EUFI.PA), a global leader in bioanalytical testing and genomic services, in its agreement to acquire Boston Heart Diagnostics Corporation (Boston Heart), an innovative heart health management company. The agreement is for an initial value of $140 million, subject to post-closing adjustments, plus an earn-out payment to the sellers that is expected to be in excess of $60 million upon achievement of certain milestones.  Fredrikson’s legal team was lead by Steven J. Dickinson and Adam J. Duerr.
Read the news release.
